A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
Also Known As:
Exelon; (S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate; ENA 713; ENA-713; Rivastigmine Hydrogen Tartrate; RivastigmineTartrate; SDZ ENA 713; 713, ENA; 713, SDZ ENA; ENA 713, SDZ; ENA713; Hydrogen Tartrate, Rivastigmine; Tartrate, Rivastigmine Hydrogen; Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)